Article authored and contributed to PharmaLeaders by: Carlo Chatman, Power PR Cell and gene therapies are dominating the world of drug development. With the promise of significant breakthroughs in treatment of diabetes, cancer, and congenital conditions, it is no wonder that research and development is predicted to reach $232.5 billion by 2026, up from $186 billion in 2019 … [Read more...]
The Importance of Pharma Marketers Engaging with the Nation’s Leading Prescribers
Contributed to PharmaLeaders by: Richard Zwickel, Chairman and CEO POCN Group Each year in the United States, about 264,000 cases of breast cancer are diagnosed in women and about 2,400 cases are diagnosed in men. Nearly 42,500 people die from the disease annually. Nurse practitioners (NPs) and physician associates (PAs) take an active role in breast cancer treatment for … [Read more...]
Switching to omnichannel in pharma: What are the challenges?
Article authored and contributed to PharmaLeaders by: Pavel Klymenko, Head of Omnichannel Hub at Viseven I've been in digital marketing for more than 15 years. From the beginning of my career, I witnessed the evolution of online communication in different markets. With the increasing number of messages sent by many companies via multiple platforms, customers got used to … [Read more...]
Validcare announces the integration of Real-World Research (RWR) Ltd into the Validcare Digital 1st CRO platform
Denver, CO. – August 2, 2022 Today, Validcare announces the integration of Real-World Research (RWR) Ltd into the Validcare Digital 1st CRO platform. RWR is a global leader in providing Real-World Evidence solutions to the pharmaceutical, biotech and medical device industries. Dr. Stuart McCully, CEO of RWR said “Until now we’ve provided sponsors with the regulatory … [Read more...]
Demystifying Machine Learning: Why Transparency Will Lead to Trust
Authored and contributed to PharmaLeaders by Michelle Marlborough, Chief Product Officer, AiCure, LLC Machine learning (ML) innovation for clinical research holds great promise for improving drug development and patient care. But, like with all new technology, increasing prevalence can be accompanied by growing skepticism. Pharmaceutical sponsors and clinicians are … [Read more...]